Eloxx Pharma
IPOEloxx Pharmaceuticals
Public · United States · $8.0M raised
- Website
- eloxxpharma.com
- Total Funding
- $8.0M
- Last Round
- $8.0M Series CAug 2017
- Rounds
- 1
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Clinical-stage biopharmaceutical company developing exaluren, a ribosome-selective readthrough therapy for Alport syndrome and ADPKD caused by nonsense mutations.
Summary
Eloxx Pharma is a Biotech company based in United States. It has raised $8.0M in total across 1 round, most recently a $8.0M Series C round in Aug 2017. Investors include LSP Life Sciences Partners.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2026
Sign up to see all 2 events
Funding: Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/eloxx-pharma"><img src="https://indexed.vc/api/badge/company/eloxx-pharma" alt="Eloxx Pharma on Indexed.vc" width="260" height="76" /></a>